Literature DB >> 8179869

Management of traumatic facial nerve paralysis with carotid artery cavernous sinus fistula.

J T Roland1, P E Hammerschlag, W S Lewis, I Choi, A Berenstein.   

Abstract

Massive skull base injuries require detailed preoperative neurological and neurovascular assessment prior to undertaking surgical repair of isolated cranial nerve deficits. We present the management of a patient with traumatic facial paralysis, cerebrospinal fluid leak, and carotid artery cavernous sinus fistula as the result of a gunshot wound to the skull base. The carotid artery cavernous sinus fistula was ultimately controlled with super-selective embolization via the vertebral artery. The facial nerve injury was then safely treated with mobilization of the labyrinthine and vertical segments to allow a primary anastomosis.

Entities:  

Mesh:

Year:  1994        PMID: 8179869     DOI: 10.1007/bf00175959

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  5 in total

Review 1.  Management of trauma of the facial nerve.

Authors:  W Y Adkins; J D Osguthorpe
Journal:  Otolaryngol Clin North Am       Date:  1991-06       Impact factor: 3.346

Review 2.  Facial nerve trauma: optimal timing for repair.

Authors:  D M Barrs
Journal:  Laryngoscope       Date:  1991-08       Impact factor: 3.325

Review 3.  Carotid-cavernous sinus fistula accompanying facial trauma. Report of a case with a review of the literature.

Authors:  Y Takenoshita; K Hasuo; T Matsushima; M Oka
Journal:  J Craniomaxillofac Surg       Date:  1990-01       Impact factor: 2.078

4.  Indirect carotid-cavernous sinus fistula: transvenous embolization from the external jugular vein using a superior ophthalmic vein approach. A case report.

Authors:  M Komiyama; K Morikawa; Y Fu; H Yagura; T Yasui; M Baba
Journal:  Surg Neurol       Date:  1990-01

5.  Carotid-cavernous sinus fistula complicating a complex shotgun facial injury.

Authors:  R Sherman; L J Gottlieb
Journal:  Ann Plast Surg       Date:  1988-09       Impact factor: 1.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.